Microsoft Windows Scripting Engine Remote Code Execution (CVE-2025-30397)

Historical catalog analysis: CISA added this entry on May 13, 2025. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.

What the vulnerability is

CVE-2025-30397 is a type confusion vulnerability (CWE-843) located within the Microsoft Windows Scripting Engine. According to CISA, this flaw could allow an unauthorized attacker to execute arbitrary code over a network by utilizing a specially crafted URL.

Exposure and applicability

This vulnerability affects systems running Microsoft Windows. In healthcare environments, this is highly applicable as Windows is frequently used for workstations, servers, and administrative interfaces that process electronic Protected Health Information (ePHI). Because the entry vector involves a crafted URL, any system exposed to network traffic or users interacting with untrusted web content could be at risk. The inclusion of this CVE in the CISA Known Exploited Vulnerabilities catalog on May 13, 2025, indicates that the flaw is being actively leveraged in the wild.

Remediation priorities

Our analysis suggests that healthcare security leaders should prioritize remediation based on the system’s role in patient care and data access. We recommend the following prioritized actions:

1. Apply Vendor Mitigations: The primary priority is to apply the official updates provided by Microsoft. This addresses the root cause of the type confusion flaw.
2. Review Cloud Service Configurations: For organizations utilizing cloud-based Windows environments, we suggest reviewing configurations in alignment with BOD 22-01 guidance to ensure mitigations are active across virtualized infrastructure.
3. Evaluate Product Necessity: In cases where a system cannot be patched—such as legacy medical devices running embedded Windows versions—security teams should evaluate if the product can be discontinued or isolated from the network if no viable mitigation exists.

How to validate remediation

To verify that exposure has been reduced, we suggest the following validation methods:

• Patch Verification: Security administrators should use authorized configuration management tools to confirm that the specific Microsoft update addressing CVE-2025-30397 is installed across all applicable workstations and servers.
• Inventory Audit: Clinical engineering teams should audit medical devices to identify those running affected Windows versions and verify if vendor-approved patches have been applied.

Note: We do not recommend performing active penetration testing or sending crafted URLs to production systems, as this could disrupt clinical operations.

Limits and open questions

While applying updates reduces the likelihood of exploitation, it does not guarantee total immunity from all network-based attacks. It remains unknown whether this vulnerability has been utilized in specific ransomware campaigns targeting healthcare providers. Additionally, while CISA has set a remediation deadline of June 3, 2025, for federal agencies, this date serves as a risk indicator rather than a legal requirement for private healthcare entities.

Source and editorial note

CVE-2025-30397: Microsoft Windows Scripting Engine Type Confusion Vulnerability · Source date: May 13, 2025 · Retrieved August 31, 2026.

Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.

Archive date: May 16, 2025. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: October 12, 2026 at 01:04 UTC.

Request a healthcare security assessment